AUSTIN, Texas--(BUSINESS WIRE)--Tricentis, a global leader in continuous testing and quality engineering, today announced its spring release of new cloud capabilities for the company’s AI-powered, ...

Providing genetic testing for BRCA1 and BRCA2 mutations in all women aged 30 years or older would be cost-effective and prevent more breast and ovarian cancers than current screening, which is based ...

Tricentis, a global leader in continuous testing and quality engineering, is introducing its spring release, adding new cloud capabilities for the company’s AI-powered, model-based test automation ...

Several frontier AI models show signs of scheming. Anti-scheming training reduced misbehavior in some models. Models know they're being tested, which complicates results. New joint safety testing from ...